Not Yet Recruiting
Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL
NCT06890585
- Conditions
- BTK Inhibitors, Double Express Diffuse Large B-cell Lymphoma, Histone Deacetylase Inhibitor
- Locations
-
- Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China